What are the indications for obtaining arterial blood gas measurements and the interpretation thresholds for initiating non‑invasive ventilation in motor neuron disease?

Blood Gas Monitoring in Motor Neuron Disease

Arterial blood gas (ABG) measurement should be obtained when PaCO2 > 45 mm Hg is suspected based on symptoms or pulmonary function testing, and this threshold directly triggers initiation of non-invasive ventilation (NIV) in motor neuron disease patients. 1

Indications for ABG Measurement

ABG testing in MND serves as part of a systematic respiratory monitoring algorithm rather than routine screening:

• Obtain ABG when pulmonary function criteria are met: FVC < 80% predicted with respiratory symptoms OR FVC < 50% without symptoms, MIP < 60 cm H2O, MEP < 40 cm H2O, or PCF < 270 L/min in patients ≥12 years 1

• Obtain ABG when respiratory symptoms develop: Morning headaches, fatigue, concentration difficulties, memory changes, shortness of breath, or witnessed apneas/gasping during sleep 1

• ABG complements overnight oximetry (ONO): When SpO2 ≤ 90% for ≥2% of sleep time is detected on ONO, ABG confirms hypercapnia 1

Critical ABG Threshold for NIV Initiation

PaCO2 > 45 mm Hg on ABG is the definitive threshold for initiating NIV in adults with MND. 1 This single measurement, when elevated, mandates NIV initiation regardless of other parameters.

Alternative to ABG in Pediatric Patients

• Capillary blood gas (CBG) can substitute for ABG in children with MND 1

Practical Clinical Algorithm

The 2023 American College of Chest Physicians guideline provides a structured approach:

1. Perform pulmonary function testing every 6 months minimum in all MND patients at risk of respiratory failure 1

2. If PFT criteria are met OR symptoms develop: Proceed to overnight oximetry 1

3. If ONO shows SpO2 ≤ 90% for ≥2% of sleep time: Obtain ABG 1

4. If ABG shows PaCO2 > 45 mm Hg: Initiate NIV immediately 1

5. Polysomnography is NOT necessary for adult MND patients to initiate NIV when PFT or ABG criteria support treatment 1

Important Clinical Nuances

ABG provides complementary information to spirometry and oximetry that improves prognostic stratification and guides timing of interventions. 2 A composite respiratory score combining forced vital capacity, ABG parameters, and overnight oximetry measurements significantly predicts survival and time to NIV adaptation in MND patients. 2

Common Pitfalls to Avoid

• Do not rely on symptoms alone: 32% of UK neurologists inappropriately used only symptoms for NIV referral, missing objective respiratory failure 3

• Avoid uncontrolled oxygen therapy: Oxygen administration before terminal phase is sometimes used inappropriately in MND patients with hypercapnia, which can worsen CO2 retention 3

• Do not wait for "prophylactic" ventilation: No evidence supports initiating NIV before ventilatory failure appears with objective measurements 4

Bulbar Dysfunction Considerations

Patients with significant bulbar impairment may not tolerate NIV or achieve adequate ventilation despite meeting ABG criteria. 1 In these cases, invasive mechanical ventilation via tracheostomy should be considered when NIV fails, bulbar function worsens, or frequent aspiration occurs. 1

Monitoring Frequency

Beyond the initial ABG when criteria are met, adjust testing frequency based on individual disease progression rate rather than fixed intervals. 1 Faster-progressing MND variants require more frequent respiratory assessment than the standard 6-month PFT schedule. 1